Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Oxaliplatin"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 468
Tytuł:
Metabolomics signature as a survival predictor in patients with resectable colorectal liver metastasis.
Autorzy:
González-Olmedo C; Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain.; Fundación Pública Andaluza para la Investigación Biosanitaria de Andalucía Oriental Alejandro Otero, University Hospital of Jaén, Jaén, Spain.; Department of Biomedicine, Translational Research and Personalised Medicine, University of Granada, Granada, Spain.
García-Verdejo FJ; Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain.
Reguera-Teba A; Department of General Surgery, University Hospital of Jaén, Jaén, Andalucia, Spain.; Department of Medicine, Faculty of Health Sciences, University of Jaén, Jaén, Spain.
Rosa-Garrido C; Fundación Pública Andaluza para la Investigación Biosanitaria de Andalucía Oriental Alejandro Otero, University Hospital of Jaén, Jaén, Spain.
López-López JA; Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain.
Díaz-Beltrán L; Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain.; Fundación Pública Andaluza para la Investigación Biosanitaria de Andalucía Oriental Alejandro Otero, University Hospital of Jaén, Jaén, Spain.
García PM; Fundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Armilla, Granada, Spain.
Luque-Caro N; Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain.
Gálvez-Montosa F; Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain.
Ortega-Granados AL; Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain.
Ruiz-Sanjuan M; Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain.; Fundación Pública Andaluza para la Investigación Biosanitaria de Andalucía Oriental Alejandro Otero, University Hospital of Jaén, Jaén, Spain.
Cózar-Ibáñez A; Department of General Surgery, University Hospital of Jaén, Jaén, Andalucia, Spain.
Sainz J; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, PTS, Granada, Spain.; Instituto de Investigación Biosanataria IBs.Granada, Granada, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health, Barcelona, Spain.; Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain.
Marchal JA; Instituto de Investigación Biosanataria IBs.Granada, Granada, Spain.; Biopathology and Regenerative Medicine Institute, Centre for Biomedical Research, University of Granada, Granada, Spain.; Department of Human Anatomy and Embryology, Faculty of Medicine, University of Granada, Granada, Spain.; Excellence Research Unit 'Modeling Nature' (MNat), University of Granada, Granada, Spain.
Camacho J; Excellence Research Unit 'Modeling Nature' (MNat), University of Granada, Granada, Spain.; Department of Signal Theory, Networking and Communications, University of Granada, Granada, Spain.
Del Palacio JP; Fundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Armilla, Granada, Spain.
Fernández-Godino R; Fundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Armilla, Granada, Spain.
Díaz C; Fundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Armilla, Granada, Spain.
Sánchez-Rovira P; Medical Oncology Unit, University Hospital of Jaén, Jaén, Spain.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2024 Jan; Vol. 14 (1), pp. e1541.
Typ publikacji:
Letter
MeSH Terms:
Colorectal Neoplasms*/surgery
Colorectal Neoplasms*/pathology
Liver Neoplasms*/surgery
Liver Neoplasms*/secondary
Humans ; Oxaliplatin
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Oxaliplatin rechallenge in metastatic colorectal cancer patients with clinically significant oxaliplatin-induced peripheral neurotoxicity.
Autorzy:
Argyriou AA; Neurological Department, Saint Andrew's General Hospital of Patras, Patras, Greece.; Department of Medicine, Division of Oncology, Medical School, University of Patras, Patras, Greece.
Kalofonou F; Department of Oncology, Imperial NHS Healthcare Trust, Charing Cross Hospital, London, UK.
Litsardopoulos P; Neurological Department, Saint Andrew's General Hospital of Patras, Patras, Greece.
Anastopoulou GG; Department of Medicine-Oncology Unit, Saint Andrew's General Hospital of Patras, Patras, Greece.
Kalofonos HP; Department of Medicine, Division of Oncology, Medical School, University of Patras, Patras, Greece.
Pokaż więcej
Źródło:
Journal of the peripheral nervous system : JPNS [J Peripher Nerv Syst] 2021 Mar; Vol. 26 (1), pp. 43-48. Date of Electronic Publication: 2020 Dec 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents/*pharmacology
Colorectal Neoplasms/*drug therapy
Heavy Metal Poisoning, Nervous System/*etiology
Neurotoxicity Syndromes/*etiology
Oxaliplatin/*pharmacology
Peripheral Nervous System Diseases/*chemically induced
Adult ; Aged ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/toxicity ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Oxaliplatin/administration & dosage ; Oxaliplatin/toxicity ; Retrospective Studies ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Small extracellular vesicles ameliorate peripheral neuropathy and enhance chemotherapy of oxaliplatin on ovarian cancer.
Autorzy:
Zhang Y; Department of Neurology Henry Ford Health System Detroit Michigan USA.
Li C; Department of Neurology Henry Ford Health System Detroit Michigan USA.
Qin Y; Department of Neurology Henry Ford Health System Detroit Michigan USA.
Cepparulo P; Department of Neurology Henry Ford Health System Detroit Michigan USA.
Millman M; Department of Physics Oakland University Rochester Michigan USA.
Chopp M; Department of Neurology Henry Ford Health System Detroit Michigan USA.; Department of Physics Oakland University Rochester Michigan USA.
Kemper A; Department of Pathology Henry Ford Health System Detroit Michigan USA.
Szalad A; Department of Neurology Henry Ford Health System Detroit Michigan USA.
Lu X; Department of Neurology Henry Ford Health System Detroit Michigan USA.
Wang L; Department of Neurology Henry Ford Health System Detroit Michigan USA.
Zhang ZG; Department of Neurology Henry Ford Health System Detroit Michigan USA.
Pokaż więcej
Źródło:
Journal of extracellular vesicles [J Extracell Vesicles] 2021 Mar; Vol. 10 (5), pp. e12073. Date of Electronic Publication: 2021 Mar 04.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Antineoplastic Agents/*therapeutic use
Extracellular Vesicles/*metabolism
Ovarian Neoplasms/*drug therapy
Oxaliplatin/*therapeutic use
Peripheral Nervous System Diseases/*therapy
Animals ; Antineoplastic Agents/adverse effects ; Axons/drug effects ; Cell Line, Tumor ; Extracellular Vesicles/transplantation ; Female ; Humans ; Mice, Inbred C57BL ; Mice, Nude ; MicroRNAs/metabolism ; Neoplasm Proteins/metabolism ; Neoplasm Transplantation ; Nerve Fibers/metabolism ; Nerve Fibers, Myelinated/metabolism ; Oxaliplatin/administration & dosage ; Oxaliplatin/adverse effects ; Peripheral Nervous System Diseases/chemically induced ; Mice
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Interspecies and in vitro-in vivo scaling for quantitative modeling of whole-body drug pharmacokinetics in patients: Application to the anticancer drug oxaliplatin.
Autorzy:
Catozzi S; Institut Curie, Inserm U900, MINES ParisTech, CBIO - Centre for Computational Biology, PSL Research University, Saint-Cloud, France.
Hill R; EPSRC and MRC Centre for Doctoral Training in Mathematics for Real-World Systems, University of Warwick, Coventry, UK.
Li XM; UPR 'Chronotherapy, Cancers and Transplantation,' Faculty of Medicine, Université Paris-Saclay, Villejuif, France.
Dulong S; Institut Curie, Inserm U900, MINES ParisTech, CBIO - Centre for Computational Biology, PSL Research University, Saint-Cloud, France.; UPR 'Chronotherapy, Cancers and Transplantation,' Faculty of Medicine, Université Paris-Saclay, Villejuif, France.
Collard E; CEA, CNRS, NIMBE, Université Paris-Saclay, Gif-sur-Yvette, France.
Ballesta A; Institut Curie, Inserm U900, MINES ParisTech, CBIO - Centre for Computational Biology, PSL Research University, Saint-Cloud, France.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Feb; Vol. 12 (2), pp. 221-235. Date of Electronic Publication: 2022 Dec 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents*/pharmacokinetics
Humans ; Rats ; Mice ; Animals ; Oxaliplatin ; Models, Biological ; Pharmacokinetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Real world, open label experience with lacosamide against acute painful oxaliplatin-induced peripheral neurotoxicity.
Autorzy:
Argyriou AA; Neurological Department, Saint Andrew's General Hospital of Patras, Patras, Greece.; Department of Medicine, Division of Oncology, Medical School, University of Patras, Patras, Greece.
Kalofonou F; Department of Oncology, Garry Weston Centre, Hammersmith Hospital, Imperial NHS Healthcare Trust, London, UK.
Litsardopoulos P; Neurological Department, Saint Andrew's General Hospital of Patras, Patras, Greece.
Anastopoulou GG; Department of Medicine-Oncology Unit, Saint Andrew's General Hospital of Patras, Patras, Greece.
Psimaras D; AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie Mazarin, Paris, France.
Bruna J; Neuro-Oncology Unit, Department of Neurology, Hospital Universitari de Bellvitge-ICO L'Hospitalet, IDIBELL, Barcelona, Spain.
Kalofonos HP; Department of Medicine, Division of Oncology, Medical School, University of Patras, Patras, Greece.
Pokaż więcej
Źródło:
Journal of the peripheral nervous system : JPNS [J Peripher Nerv Syst] 2020 Jun; Vol. 25 (2), pp. 178-183. Date of Electronic Publication: 2020 Apr 29.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents/*toxicity
Colorectal Neoplasms/*drug therapy
Lacosamide/*pharmacology
Neuralgia/*drug therapy
Neurotoxicity Syndromes/*drug therapy
Oxaliplatin/*toxicity
Peripheral Nervous System Diseases/*drug therapy
Voltage-Gated Sodium Channel Blockers/*pharmacology
Acute Disease ; Aged ; Antineoplastic Agents/administration & dosage ; Female ; Humans ; Lacosamide/administration & dosage ; Male ; Middle Aged ; Neuralgia/chemically induced ; Neurotoxicity Syndromes/etiology ; Outcome Assessment, Health Care ; Oxaliplatin/administration & dosage ; Peripheral Nervous System Diseases/chemically induced ; Pilot Projects ; Prospective Studies ; Voltage-Gated Sodium Channel Blockers/administration & dosage
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Voltage-gated sodium channel dysfunction and the search for other satellite channels in relation to acute oxaliplatin-induced peripheral neurotoxicity.
Autorzy:
Argyriou AA; Department of Neurology, 'Saint Andrew's' State General Hospital of Patras, Greece.
Park SB; The University of Sydney, Brain and Mind Centre, Faculty of Medicine and Health, Sydney, Australia.
Bruna J; Unit of Neuro-Oncology, Hospital Universitari de Bellvitge-ICO L'Hospitalet-IDIBELL, Barcelona, Spain.
Cavaletti G; Experimental Ueurology Unit, University of Milano-Bicocca, Monza, Italy and NeuroMI (Milan Center for Neuroscience), Milan, Italy.
Pokaż więcej
Źródło:
Journal of the peripheral nervous system : JPNS [J Peripher Nerv Syst] 2019 Dec; Vol. 24 (4), pp. 360-361. Date of Electronic Publication: 2019 Nov 07.
Typ publikacji:
Letter; Comment
MeSH Terms:
Oxaliplatin*
Potassium Channels, Voltage-Gated*
Organoplatinum Compounds ; Sodium ; Voltage-Gated Sodium Channels
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Role of lncSLCO1C1 in gastric cancer progression and resistance to oxaliplatin therapy.
Autorzy:
Xiao YF; Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Li BS; Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Liu JJ; Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Wang SM; Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Liu J; Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Yang H; Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Hu YY; Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Gong CL; Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Li JL; Wenzhou Medical University Eye Hospital and School of Biomedical Engineering, China.; Cancer Research Centre, University of Chinese Academy of Sciences Wenzhou Institute, Wenzhou, China.; Institute of Translational and Stratified Medicine, University of Plymouth Faculty of Medicine and Dentistry, Plymouth, UK.
Yang SM; Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2022 Apr; Vol. 12 (4), pp. e691.
Typ publikacji:
Journal Article
MeSH Terms:
MicroRNAs*/genetics
MicroRNAs*/metabolism
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Stomach Neoplasms*/drug therapy
Stomach Neoplasms*/genetics
Stomach Neoplasms*/metabolism
DNA-Binding Proteins/genetics ; DNA-Binding Proteins/metabolism ; Disease Progression ; High Mobility Group Proteins/genetics ; High Mobility Group Proteins/metabolism ; Humans ; Organic Anion Transporters ; Oxaliplatin/pharmacology ; Transcriptional Elongation Factors/genetics ; Transcriptional Elongation Factors/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Platinum accumulation in oxaliplatin-induced peripheral neuropathy.
Autorzy:
Wei G; Department of Oncology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.; Graduate school, Nanjing University of Chinese Medicine, Nanjing, China.; Department of Oncology, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China.
Gu Z; Department of Oncology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.; Graduate school, Nanjing University of Chinese Medicine, Nanjing, China.
Gu J; Department of Oncology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.; Graduate school, Nanjing University of Chinese Medicine, Nanjing, China.
Yu J; Department of Oncology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.; Department of Oncology, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China.
Huang X; Department of Oncology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.; Graduate school, Nanjing University of Chinese Medicine, Nanjing, China.; Department of Oncology, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China.
Qin F; Department of Oncology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.; Graduate school, Nanjing University of Chinese Medicine, Nanjing, China.; Department of Oncology, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China.
Li L; Department of Oncology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.; Department of Oncology, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China.
Ding R; Department of Oncology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.; Department of Oncology, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China.
Huo J; Department of Oncology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.; Department of Oncology, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China.
Pokaż więcej
Źródło:
Journal of the peripheral nervous system : JPNS [J Peripher Nerv Syst] 2021 Mar; Vol. 26 (1), pp. 35-42. Date of Electronic Publication: 2021 Jan 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Antineoplastic Agents/*toxicity
Ganglia, Spinal/*drug effects
Ganglia, Spinal/*metabolism
Heavy Metal Poisoning, Nervous System/*metabolism
Neurotoxicity Syndromes/*metabolism
Oxaliplatin/*toxicity
Peripheral Nervous System Diseases/*chemically induced
Peripheral Nervous System Diseases/*metabolism
Platinum/*metabolism
Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Folate receptor α increases chemotherapy resistance through stabilizing MDM2 in cooperation with PHB2 that is overcome by MORAb-202 in gastric cancer.
Autorzy:
Sakai H; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
Kawakami H; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
Teramura T; Division of Cell Biology for Regenerative Medicine, Institute of Advanced Clinical Medicine, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
Onodera Y; Division of Cell Biology for Regenerative Medicine, Institute of Advanced Clinical Medicine, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
Somers E; AD Franchise Special Mission, Eisai Inc., Woodcliff Lake, New Jersey, USA.
Furuuchi K; Epochal Precision Anti-Cancer Therapeutics (EPAT), Eisai Inc., Exton, Pennsylvania, USA.
Uenaka T; Epochal Precision Anti-Cancer Therapeutics (EPAT), Eisai Inc., Exton, Pennsylvania, USA.
Kato R; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
Nakagawa K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2021 Jun; Vol. 11 (6), pp. e454.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies, Monoclonal, Humanized/*pharmacology
Drug Resistance, Neoplasm/*drug effects
Folate Receptor 1/*metabolism
Furans/*pharmacology
Gene Expression Regulation, Neoplastic/*drug effects
Ketones/*pharmacology
Prohibitins/*metabolism
Proto-Oncogene Proteins c-mdm2/*chemistry
Stomach Neoplasms/*drug therapy
Animals ; Antineoplastic Agents/pharmacology ; Apoptosis ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Cell Proliferation ; Female ; Folate Receptor 1/genetics ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Oxaliplatin/pharmacology ; Prognosis ; Prohibitins/genetics ; Proteome ; Proto-Oncogene Proteins c-mdm2/genetics ; Proto-Oncogene Proteins c-mdm2/metabolism ; Stomach Neoplasms/genetics ; Stomach Neoplasms/metabolism ; Stomach Neoplasms/pathology ; Survival Rate ; Transcriptome ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Neoadjuvant S‐1 and oxaliplatin plus bevacizumab therapy for high‐risk locally advanced rectal cancer: A prospective multicenter phase II study
Autorzy:
Takuya Miura
Hajime Morohashi
Yoshiyuki Sakamoto
Takuji Kagiya
Tatsuya Hasebe
Yoshihito Nakayama
Hiromasa Fujita
Kenichi Hakamada
Pokaż więcej
Temat:
bevacizumab
locally advanced rectal cancer
neoadjuvant chemotherapy
oxaliplatin
S‐1
Surgery
RD1-811
Diseases of the digestive system. Gastroenterology
RC799-869
Źródło:
Annals of Gastroenterological Surgery, Vol 8, Iss 1, Pp 71-79 (2024)
Opis pliku:
electronic resource
Relacje:
https://doaj.org/toc/2475-0328
Dostęp URL:
https://doaj.org/article/459fb524fdc34ef9bab27c62b395d789  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Relapsed urachal carcinoma responding to first‐line chemotherapy with capecitabine‐oxaliplatin plus bevacizumab
Autorzy:
Akihiko Hatano
Kunihiko Wakaki
Norio Miyajima
Shuichi Komatsu
Pokaż więcej
Temat:
bevacizumab
capecitabine
chemotherapy
oxaliplatin
urachal carcinoma
Diseases of the genitourinary system. Urology
RC870-923
Źródło:
IJU Case Reports, Vol 6, Iss 6, Pp 345-348 (2023)
Opis pliku:
electronic resource
Relacje:
https://doaj.org/toc/2577-171X
Dostęp URL:
https://doaj.org/article/7a2c3f671a5a403aafe2f27b2f764119  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Patient-derived organoids in cellulosic sponge model chemotherapy response of metastatic colorectal cancer.
Autorzy:
Xu Y; Med-X Research Institute & School of Biomedical Engineering, Shanghai Jiaotong University, Shanghai, China.; State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Stem Cell Research Center, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Chen J; Department of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Huang Y; Department of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Luo Y; Department of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Hsieh AC; Pishon Biomedical Co., Ltd, Taipei, Taiwan, China.
Chen J; Pishon Biomedical Co., Ltd, Taipei, Taiwan, China.
Li H; Med-X Research Institute & School of Biomedical Engineering, Shanghai Jiaotong University, Shanghai, China.; State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Stem Cell Research Center, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Wei X; Med-X Research Institute & School of Biomedical Engineering, Shanghai Jiaotong University, Shanghai, China.; Biomedical Engineering Department, Peking University, Beijing, China.; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China.
Gao WQ; Med-X Research Institute & School of Biomedical Engineering, Shanghai Jiaotong University, Shanghai, China.; State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Stem Cell Research Center, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Zhong M; Department of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Zhang Y; Med-X Research Institute & School of Biomedical Engineering, Shanghai Jiaotong University, Shanghai, China.; State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Stem Cell Research Center, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2021 Jan; Vol. 11 (1), pp. e285.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents/*pharmacology
Cell Culture Techniques/*methods
Colorectal Neoplasms/*drug therapy
Fluorouracil/*pharmacology
Organoids/*drug effects
Oxaliplatin/*pharmacology
Animals ; Cells, Cultured ; Collagen ; Colorectal Neoplasms/pathology ; Drug Combinations ; Humans ; In Vitro Techniques ; Laminin ; Proteoglycans
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
RAB31 drives extracellular vesicle fusion and cancer‐associated fibroblast formation leading to oxaliplatin resistance in colorectal cancer
Autorzy:
Yu‐Chan Chang
Yi‐Fang Yang
Chien‐Hsiu Li
Ming‐Hsien Chan
Meng‐Lun Lu
Ming‐Huang Chen
Chi‐Long Chen
Michael Hsiao
Pokaż więcej
Temat:
AGR2
colon cancer
epithelial‐mesenchymal transition
oxaliplatin resistance
RAB31
Cytology
QH573-671
Źródło:
Journal of Extracellular Biology, Vol 3, Iss 2, Pp n/a-n/a (2024)
Opis pliku:
electronic resource
Relacje:
https://doaj.org/toc/2768-2811
Dostęp URL:
https://doaj.org/article/91bff575744145e79f660e623345075f  Link otwiera się w nowym oknie
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Oxaliplatin- and docetaxel-induced polyneuropathy: clinical and neurophysiological characteristics.
Autorzy:
Bennedsgaard K; Danish Pain Research Center, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Ventzel L; Danish Pain Research Center, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Andersen NT; Biostatistics, Department of Public Health, Aarhus University, Aarhus, Denmark.
Themistocleous AC; Nuffield Department of Clinical Neuroscience, University of Oxford, UK.; Brain Function Research Group, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Bennett DL; Nuffield Department of Clinical Neuroscience, University of Oxford, UK.
Jensen TS; Danish Pain Research Center, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Tankisi H; Department of Neurophysiology, Aarhus University Hospital, Aarhus, Denmark.
Finnerup NB; Danish Pain Research Center, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.
Pokaż więcej
Źródło:
Journal of the peripheral nervous system : JPNS [J Peripher Nerv Syst] 2020 Dec; Vol. 25 (4), pp. 377-387. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Severity of Illness Index*
Antineoplastic Agents/*adverse effects
Diagnostic Techniques, Neurological/*standards
Docetaxel/*adverse effects
Neoplasms/*drug therapy
Oxaliplatin/*adverse effects
Polyneuropathies/*chemically induced
Polyneuropathies/*diagnosis
Aged ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neuralgia/chemically induced ; Neuralgia/diagnosis ; Neuralgia/pathology ; Neuralgia/physiopathology ; Polyneuropathies/pathology ; Polyneuropathies/physiopathology ; Prospective Studies ; Quality of Life
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Liability of the voltage-gated potassium channel KCNN3 repeat polymorphism to acute oxaliplatin-induced peripheral neurotoxicity.
Autorzy:
Argyriou AA; Department of Neurology, 'Saint Andrew's' State General Hospital of Patras, Rion-Patras, Greece.; Department of Medicine, Division of Oncology, Clinical and Molecular Oncology Laboratory, University of Patras, Rion-Patras, Greece.
Antonacopoulou AG; Department of Medicine, Division of Oncology, Clinical and Molecular Oncology Laboratory, University of Patras, Rion-Patras, Greece.
Alberti P; Experimental Neurology Unit, University of Milano-Bicocca, Monza, Italy.; NeuroMI (Milan Center for Neuroscience), Milan, Italy.
Briani C; Department of Neurosciences, University of Padova, Padova, Italy.
Bruna J; Unit of Neuro-Oncology, Hospital Universitari de Bellvitge-ICO L'Hospitalet-IDIBELL, Barcelona and Department of Cell Biology, Physiology and Immunology, Institute of Neurosciences, Universitat Autònoma de Barcelona, and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Bellaterra, Spain.
Velasco R; Unit of Neuro-Oncology, Hospital Universitari de Bellvitge-ICO L'Hospitalet-IDIBELL, Barcelona and Department of Cell Biology, Physiology and Immunology, Institute of Neurosciences, Universitat Autònoma de Barcelona, and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Bellaterra, Spain.
Anastopoulou GG; Department of Medicine, Division of Oncology, 'Saint Andrew's' State General Hospital of Patras, Rion-Patras, Greece.
Park SB; Brain and Mind Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Cavaletti G; Experimental Neurology Unit, University of Milano-Bicocca, Monza, Italy.; NeuroMI (Milan Center for Neuroscience), Milan, Italy.
Kalofonos HP; Department of Medicine, Division of Oncology, Clinical and Molecular Oncology Laboratory, University of Patras, Rion-Patras, Greece.
Pokaż więcej
Źródło:
Journal of the peripheral nervous system : JPNS [J Peripher Nerv Syst] 2019 Dec; Vol. 24 (4), pp. 298-303. Date of Electronic Publication: 2019 Oct 16.
Typ publikacji:
Journal Article
MeSH Terms:
Neurotoxicity Syndromes*/etiology
Neurotoxicity Syndromes*/genetics
Neurotoxicity Syndromes*/physiopathology
Peripheral Nervous System Diseases*/chemically induced
Peripheral Nervous System Diseases*/genetics
Peripheral Nervous System Diseases*/physiopathology
Antineoplastic Agents/*toxicity
Colorectal Neoplasms/*drug therapy
Oxaliplatin/*toxicity
Aged ; Female ; Humans ; Male ; Middle Aged ; Polymorphism, Genetic ; Severity of Illness Index ; Trinucleotide Repeats
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Platinum-induced peripheral neurotoxicity: From pathogenesis to treatment.
Autorzy:
Staff NP; Department of Neurology, Mayo Clinic, Rochester, Minnesota.
Cavaletti G; Experimental Neurology Unit, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Islam B; Laboratory Sciences and Services Division, The International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
Lustberg M; Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
Psimaras D; OncoNeuroTox Group, Center for Patients with Neurological Complications of Oncologic Treatments, Hôpitaux Universitaires Pitié-Salpetrière-Charles Foix et Hôpital Percy, Paris, France.
Tamburin S; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Pokaż więcej
Źródło:
Journal of the peripheral nervous system : JPNS [J Peripher Nerv Syst] 2019 Oct; Vol. 24 Suppl 2, pp. S26-S39.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms:
Antineoplastic Agents/*adverse effects
Neurotoxicity Syndromes/*therapy
Organoplatinum Compounds/*adverse effects
Peripheral Nervous System Diseases/*chemically induced
Peripheral Nervous System Diseases/*therapy
Cisplatin/adverse effects ; Duloxetine Hydrochloride/therapeutic use ; Humans ; Neurotoxicity Syndromes/diagnosis ; Oxaliplatin/adverse effects ; Peripheral Nervous System Diseases/diagnosis ; Serotonin and Noradrenaline Reuptake Inhibitors/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of gemcitabine plus oxaliplatin versus gemcitabine plus nab‐paclitaxel as first‐line chemotherapy for advanced pancreatic adenocarcinoma: A single‐center retrospective analysis
Autorzy:
Konstantin Schlick
Antonia Gantschnigg
Alexander Seymer
Florian Huemer
Richard Greil
Lukas Weiss
Pokaż więcej
Temat:
gemcitabine
GEMOX
nab‐paclitaxel
oxaliplatin
pancreatic cancer
treatment costs
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Źródło:
Cancer Medicine, Vol 12, Iss 16, Pp 16997-17004 (2023)
Opis pliku:
electronic resource
Relacje:
https://doaj.org/toc/2045-7634
Dostęp URL:
https://doaj.org/article/b9a49e1c5b3e43409a6abf40578766f3  Link otwiera się w nowym oknie
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cancer Nanobombs Delivering Artoxplatin with a Polyigniter Bearing Hydrophobic Ferrocene Units Upregulate PD‐L1 Expression and Stimulate Stronger Anticancer Immunity
Autorzy:
Yongchao Gao
Hanchen Zhang
Lin Tang
Feifei Li
Li Yang
Haihua Xiao
Johannes Karges
Weihua Huang
Wei Zhang
Chaoyong Liu
Pokaż więcej
Temat:
artoxplatin
chemo‐immunotherapy
immunogenic cell death
oxaliplatin
reactive oxygen species
Science
Źródło:
Advanced Science, Vol 11, Iss 4, Pp n/a-n/a (2024)
Opis pliku:
electronic resource
Relacje:
https://doaj.org/toc/2198-3844
Dostęp URL:
https://doaj.org/article/39ec65a897da43c590aac496dd00cde9  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Oxaliplatin, neurotoxicity, and the search for the lost channel.
Autorzy:
Modoni A; Unit of Neurology, Fondazione Policlinico Universitario 'A. Gemelli'-IRCCS, Rome, Italy.
Basso M; Unit of Oncology, Fondazione Policlinico Universitario 'A. Gemelli'-IRCCS, Rome, Italy.
Pokaż więcej
Źródło:
Journal of the peripheral nervous system : JPNS [J Peripher Nerv Syst] 2019 Dec; Vol. 24 (4), pp. 359. Date of Electronic Publication: 2019 Nov 06.
Typ publikacji:
Letter; Comment
MeSH Terms:
Neurotoxicity Syndromes*
Potassium Channels, Voltage-Gated*
Humans ; Organoplatinum Compounds ; Oxaliplatin ; Small-Conductance Calcium-Activated Potassium Channels
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 468

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies